Appropriateness of primary prevention implantable cardioverter- defibrillators at the time of generator replacement: Are indications still met?

Journal of the American College of Cardiology

Volumn 63, Issue 22, 2014, Pages 2388-2394

  Kini, Vinay ^a   Soufi, Mohamad Khaled ^b   Deo, Rajat ^a   Epstein, Andrew E ^a,b   Bala, Rupa ^a   Riley, Michael ^a   Groeneveld, Peter W ^b   Shalaby, Alaa ^b   Dixit, Sanjay ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ICD generator replacement; implantable cardioverter defibrillator; sudden cardiac death

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; COMORBIDITY; CONTROLLED STUDY; COST CONTROL; DUAL CHAMBER PACEMAKER; ELECTRIC BATTERY; GENERATOR; HEALTH CARE COST; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; SINGLE CHAMBER PACEMAKER; SURVIVAL RATE; TREATMENT INDICATION; CLINICAL ASSESSMENT; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG USE; GENERATOR REPLACEMENT; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; ISCHEMIC CARDIOMYOPATHY; MEDICAL PROCEDURES; NONISCHEMIC CARDIOMYOPATHY; PATIENT SELECTION; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SUDDEN CARDIAC DEATH; VETERAN;

ICD GENERATOR REPLACEMENT; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; SUDDEN CARDIAC DEATH;

AGED; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; RETREATMENT; RETROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 84902096058     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.03.025     Document Type: Article

References (26)

1. A.E. Buxton, K.L. Lee, and J.D. Fisher et al. A randomized study of the prevention of sudden death in patients with coronary artery disease (MUSTT) N Engl J Med 341 1999 1882 1890
2. A.J. Moss, W. Zareba, and W.J. Hall et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction (MADIT-II) N Engl J Med 346 2002 877 883
3. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure (SCD-HeFT) N Engl J Med 352 2005 225 237
4. A.E. Epstein, J.P. Dimarco, and K.A. Ellenbogen et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities J Am Coll Cardiol 51 2008 e1 e62
5. D.N. Sharpe, J. Murphy, R. Coxon, and S.F. Hannan Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study Circulation 70 1984 271 278
6. C. Linde, W.T. Abraham, M.R. Gold, M. St John Sutton, S. Ghio, and C. Daubert Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 2008 1834 1843
7. A.D. Krahn, D.S. Lee, and D. Birnie et al. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD database Circ Arrhythm Electrophysiol 4 2011 136 142
8. J.E. Poole, M.J. Gleva, and T. Mela et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry Circulation 122 2010 1553 1561
9. D.B. Kramer, K.F. Kennedy, and P.A. Noseworthy et al. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR Circ Cardiovasc Qual Outcomes 6 2013 488 497
10. J.E. Poole, G.W. Johnson, and A.S. Hellkamp et al. Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
11. R. Tung, P. Zimetbaum, and M.E. Josephson A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death J Am Coll Cardiol 52 2008 1111 1121
12. S.C. Hammill, M.S. Kremers, and L.W. Stevenson et al. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure Heart Rhythm 7 2010 1340 1345
13. Centers for Medicare and Medicaid Services. Hospital outpatient prospective payment - final rule with comment period and CY2013 payment rates. Available at: http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ HospitalOutpatientPPS/Hospital-Outpatient-Regulations-and-Notices-Items/ CMS-1589-FC.html?Page=1&DLSort=2&DLSortDir=descending. Accessed August 9, 2013.
14. Centers for Medicare and Medicaid Services. Medicare physician fee schedule. Available at: http://www.cms.gov/apps/physician-fee-schedule/overview. aspx. Accessed August 9, 2013.
15. Centers for Medicare and Medicaid Services. National Coverage Determination (NCD) for Implantable Automatic Defibrillators (20.4). Available at: http://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx? NCDId=110&ncdver=3&IsPopup=y&NCAId=102&NcaName= Implantable+Defibrillators+-+Clinical+Trials&bc=AAAAAAAAIAAA&. Accessed October 21, 2013.
16. J.E. Schliamser, A.H. Kadish, and H. Subacius et al. Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-ischemic Cardiomyopathy Treatment Evaluation Trial Heart Rhythm 10 2013 838 846
17. N. Naksuk, A. Saab, and J. Li et al. Incidence of appropriate shock in implantable cardioverter-defibrillator patients with improved ejection fraction J Cardiac Fail 19 2013 426 430
18. K.A. Ellenbogen, J.H. Levine, and R.D. Berger et al. Are implantable cardioverter-defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 113 2006 776 782
19. S.G. Kim, R.N. Fogoros, S. Furman, S.J. Connolly, K.H. Kuck, and A.J. Moss Standardized reporting of ICD patient outcome: the report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9-10, 1993 Pacing and Clinical Electrophysiology 16 1993 1358 1362
20. J.B. Van Rees, C.J. Borleffs, and M.K. de Bie et al. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality J Am Coll Cardiol 57 2011 556 562
21. G.D. Sanders, M.A. Hlatky, and D.K. Owens Cost-effectiveness of implantable cardioverter-defibrillators N Engl J Med 353 2005 1471 1480
22. G. Yao, N. Freemantle, and M.J. Calvert et al. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator Eur Heart J 28 2007 42 51
23. The Multicenter Postinfarction Research Group Risk stratification and survival after myocardial infarction N Engl J Med 309 1983 331 336
24. J.L. Rouleau, M. Talajic, and B. Sussex et al. Myocardial infarction patients in the 1990s - their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study J Am Coll Cardiol 27 1996 1119 1127
25. J.A. Manfredi, S.M. Al-Khatib, and L.K. Shaw et al. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias Circ Arrhythm Electrophysiol 6 2013 257 264
26. M. Manne, J. Rickard, N. Varma, M.K. Chung, and P. Tchou Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival Pacing Clin Electrophysiol 36 2013 970 977